[
177
Lu]Lu-DOTATATE May Resensitize Neuroendocrine Tumors to Hormonal Therapy: Initial Clinical Experience in Renal Carcinoid
J Nucl Med
.
2024 May 16:jnumed.124.267497.
doi: 10.2967/jnumed.124.267497.
Online ahead of print.
Authors
Akram Al-Ibraheem
1
2
,
Ahmed Abdlkadir
3
,
Dhuha Al-Adhami
3
,
Ken Herrmann
4
5
Affiliations
1
Department of Nuclear Medicine, King Hussein Cancer Center, Amman, Jordan; aibraheem@khcc.jo.
2
School of Medicine, University of Jordan, Amman, Jordan.
3
Department of Nuclear Medicine, King Hussein Cancer Center, Amman, Jordan.
4
Department of Nuclear Medicine, West German Cancer Center, University Hospital Essen, Essen, Germany; and.
5
German Cancer Consortium, Partner Site University Hospital Essen, Essen, Germany.
PMID:
38754958
DOI:
10.2967/jnumed.124.267497
No abstract available